Reuters logo
BRIEF-Kura Oncology Inc entered into amendment to its sales agreement with Cowen and Co
November 9, 2017 / 10:15 PM / 9 days ago

BRIEF-Kura Oncology Inc entered into amendment to its sales agreement with Cowen and Co

Nov 9 (Reuters) - Kura Oncology Inc

* Kura Oncology Inc - on Nov 9, 2017, co entered into amendment to its sales agreement, dated January 27, 2017 with Cowen and Company LLC ‍​-SEC filing

* Kura Oncology Inc - under the agreement, co increased maximum aggregate offering price of the shares of its common stock, par value $0.0001 per share Source text: (bit.ly/2zqW8C3) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below